Information for Attendees of the 2010 AIBD Conference


Scheduling, registration, and other information for attendees of the 2010 Advances in Inflammatory Bowel Diseases, Clinical & Research Conference.

WHAT: 2010 Advances in Inflammatory Bowel Diseases, Clinical & Research Conference

WHERE: Hollywood, FL

WHEN: December 9-12, 2010

The 2010 Advances in Inflammatory Bowel Diseases, Clinical & Research Conference will feature the latest information on IBD treatment and emerging research. The conference is designed to enable clinicians and researchers from all over the world who are working to understand the causes of Crohn's disease and ulcerative colitis to come together to share and gain knowledge. Endorsed by the American College of Gastroenterology (ACG); the American Gastroenterological Association (AGA); and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN), this year's conference will include expanded sessions on and coverage of advances in IBD procedures and surgeries, pediatric IBD, adaptive immunity, and more.


Early registration ended December 2, but you can still visit the 2010 AIBD registration page to learn more about the registration process and fees.

Conference Objectives

According to the 2010 AIBD conference brochure and announcement, this year’s event will present information on:

  • Recent clinical trial data regarding the next generation of biologic therapies in IBD
  • Reducing the risk of undetected infections or misdiagnoses by increasing their frequency of testing for stool pathogens
  • Improving patient safety by increasing their frequency of TB testing prior to starting patients on antiTNF therapy
  • Protecting patients from adverse events when prescribing thiopurine-class drugs by testing more often for thiopurine methyltransferase (TPMT)
  • Current best practices related to treating children with IBD, especially the use of immunomodulators and biologics
  • Therapy options for hospitalized children with steroid-refractory ulcerative colitis
  • Arguments for and against targeted biopsies during cancer surveillance colonoscopy
  • Advanced management strategies for improving quality of care for patients with IBD
  • Arguments for and against making mucosal healing a standard therapeutic endpoint
  • Selecting the most appropriate pharmacologic therapy for pregnant patients
  • Research questions related to the basic science of IBD, especially genetics, immunology, or oncology


Click here to access listing of the oral and poster presentations that have been accepted for AIBD 2010.

Scientific Agenda and Schedule

The 2010 AIBD Scientific Agenda is divided into two tracks: a Clinical Track and a Research Track. The Agenda-at-a-Glance offers scheduling information for both tracks. More detailed information about the Friday, Saturday, and Sunday schedules is also available online.


A webcast and podcast summary of the 2009 conference are posted at the AIBD conference website.

Related Videos
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
Ghada Bourjeily, MD: Research Gaps on Sleep Issues During Pregnancy
John Winkelman, MD, PhD: When to Use Low-Dose Opioids for Restless Legs Syndrome
Bhanu Prakash Kolla, MBBS, MD: Treating Sleep with Psychiatric Illness
© 2024 MJH Life Sciences

All rights reserved.